Evidence map›Paper›PMID 42358821›Full record

ArticleOncology research2026

Lei Luo, Fengju Guan, Zhankun Wang, Bin Li, Xuemei Ding, Leilei Song, Lijiang Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lei LuoUrological Department, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Shinan District, Qingdao, China.
Fengju GuanUrological Department, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Shinan District, Qingdao, China.
Zhankun WangUrological Department, Qingdao Eighth People's Hospital, No. 84, Fengshan Road, Licang District, Qingdao, China.
Bin LiUrological Department, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Shinan District, Qingdao, China.
Xuemei DingUrological Department, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Shinan District, Qingdao, China.
Leilei SongUrological Department, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Shinan District, Qingdao, China.
Lijiang SunUrological Department, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Shinan District, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Renal CellDrug Resistance, NeoplasmInterferon Regulatory Factor-1Kidney NeoplasmsPoly(ADP-ribose) PolymerasesSTAT1 Transcription FactorSunitinibCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansPhthalazinesPiperazinesSignal TransductionInterferon Regulatory Factor-1IRF1 protein, humanolaparibPhthalazinesPiperazinesPoly(ADP-ribose) PolymerasesSTAT1 protein, humanSTAT1 Transcription FactorSunitinibClear cell renal cell carcinomaISG15PARP9STAT1/IRF1 signaling pathwaysunitinib resistance

Identifiers

PMID42358821
PMCPMC13292067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.